YAP/TAZ control HCC progression through multiple mechanisms including crosstalk with protumorigenic pathways [41–45] and interaction with metabolic processes [46, 47] and stemness factors [48, 49]. This evidence concerns the gene YAP1 and hepatocellular carcinoma.